FDA Inspection 1242972 — Arifulla Khan MD
The FDA completed an inspection of Arifulla Khan MD on June 25, 2024 in Bellevue, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 25, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Bellevue, WA (United States)
Additional Details
Clinical Investigator (CI)